Valuation · US stocks
Disc Medicine, Inc. (IRON) valuation
As of 2026-11-18, Disc Medicine, Inc. trades at $77.98, below the lowest fair-value bound of its 1, 3 and 5-year windows.
- Price
- $77.98
- Day change
- +1.84%
- Market cap
- $3.70B
- Sector
- Biotechnology
- Valuation
- Below band
- As of
- 2026-11-18
Other Biotechnology stocks
| Stock | Price | Market cap | Valuation |
|---|---|---|---|
| Amgen Inc. AMGN | $443.89 | $251.94B | High |
| Gilead Sciences, Inc. GILD | $168.98 | $181.83B | Above band |
| Moderna, Inc. MRNA | $196.79 | $93.61B | Above band |
| Natera, Inc. NTRA | $289.50 | $44.78B | Fair |
| IQVIA Holdings Inc IQV | $257.80 | $42.67B | Above band |
| United Therapeutics Corporation UTHR | $577.34 | $24.09B | Above band |
| Neurocrine Biosciences, Inc. NBIX | $162.86 | $16.76B | Fair |
| Summit Therapeutics Inc SMMT | $10.50 | $13.99B | Fair |
| Elanco Animal Health, Inc. ELAN | $26.69 | $13.41B | Above band |
| Halozyme Therapeutics, Inc. HALO | $95.80 | $11.76B | High |
| Twist Bioscience Corp. TWST | $116.35 | $11.50B | Above band |
| Bio-Techne Corporation TECH | $72.75 | $11.44B | Fair |
How the valuation band works
Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.